American Journal of Drug Discovery and Development
Year: 2013 | Volume: 3 | Issue: 3 | Page No.: 188-193
Citation to this article as recorded by 
|
On which evidence can we rely when prescribing off-label methotrexate in dermatological practice? – a systematic review with GRADE approach Journal of Dermatological Treatment Vol. 33, Issue 4, 1947, 2022 |
|
Shedding light on therapeutics in alopecia and their relevance to COVID-19 Clinics in Dermatology Vol. 39, Issue 1, 76, 2021 |
|
Methotrexat bei Alopecia areata/totalis? ästhetische dermatologie & kosmetologie Vol. 11, Issue 1, 19, 2019 |
|
Methotrexate for alopecia areata: A systematic review and meta-analysis Journal of the American Academy of Dermatology Vol. 80, Issue 1, 120, 2019 |
|
Efficacy and Safety of Methotrexate in Combination with Mini Pulse Doses of Methylprednisolone in Severe Alopecia Areata. The Vietnamese Experience Open Access Macedonian Journal of Medical Sciences Vol. 7, Issue 2, 200, 2019 |
|
Is methotrexate an effective and safe treatment for maintaining hair regrowth in people with alopecia totalis? A Critically Appraised Topic British Journal of Dermatology Vol. 179, Issue 3, 609, 2018 |
|
Methotrexate/prednisolone Reactions Weekly Vol. 1549, Issue 1, 172, 2015 |
How to cite this article
A.R. Firooz and D.F. Fouladi, 2013. Methotrexate Plus Prednisolone in Severe Alopecia Areata. American Journal of Drug Discovery and Development, 3: 188-193.
DOI: 10.3923/ajdd.2013.188.193
URL: https://scialert.net/abstract/?doi=ajdd.2013.188.193
DOI: 10.3923/ajdd.2013.188.193
URL: https://scialert.net/abstract/?doi=ajdd.2013.188.193